The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Biologics Market size, share, analysis future and forecast 2030 comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape. The research company provides an extensive range of strategic reports on diverse industry verticals to substantial and varied client bases, including multinational corporations, financial institutions, governments, and individuals, among others.
Detail Overview of Biologics Industry Size (2025-2030):
According to the latest report, the Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% from 2025 to 2030. The report significantly addressed considerable changes, gap analyses, and competitive studies using qualitative and quantitative data.
Request Sample Report or Discuss More – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
Biologics Market Coverage:
- Historic Period: 2020-23
- Base year: 2024
- Forecast Years: 2025-2030
- Risk & Swot Analysis
- Growth parameters influence Biologics market dynamics
Market Dynamics:
Growth Opportunity-
Biotechnology Techniques ‘CRISPR-Cas9’ to Revolutionize Biologics Drug Development in Future Years – The adoption of CRISPR-Cas9 technology among the Biologics drugs offering companies for research & development purposes possesses significant opportunities for market growth. This technology holds immense potential for developing next-generation biologics by correcting genetic defects or enhancing therapeutic efficacy, thus boosting the development of biologics drugs on a large scale. For instance:
- In 2023, the FDA approved the first gene therapies, i.e., Casgevy and Lyfgenia, to treat Sickle Cell Disease (SCD). Casgevy is the first FDA-approved therapy using CRISPR/Cas9 to edit patients’ blood stem cells.
Hence, the adoption of CRISPR-Cas9 technology allows companies to effectively develop biologics, like gene therapies, thus holding immense potential for the growth of the Biologics Market in the coming years.
Recent Advancement:
- 2023: Amgen announced the completion of the acquisition of biologics market player, Horizon Therapeutics, which is aligned with its vision for the development of drugs for patients with rare diseases.
Notable Biologics Market Players – Business Description, Product Portfolio, Strategic Alliances or Partnerships, Developments and Financial Details
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- Janssen Biotech, Inc.
- Bayer AG
- Merck & Co.
- Amgen Inc.
- Abbott GmbH
- Novartis
- AstraZeneca Plc
- GlaxoSmithKline Biologicals
- Moderna, Inc.
- Ferring Pharmaceuticals Inc.
- Aimmune Therapeutics, Inc.
- Hoffman La Roche
- Others
Access the Complete Report for An In-Depth Analysis – https://www.marknteladvisors.com/research-library/global-biologics-market.html
Segmentation of Biologics Market:
- By Therapeutic Application (Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Cardiovascular Diseases, Others (Inflammatory Bowel Diseases, RespiratoryDisorders, Ophthalmic Disorders, etc.))
- By Drug Class (Recombinant Proteins, [Hormones, Cytokines], Monoclonal Antibodies, Blood & Blood Components, Cellular & Gene Therapy, Vaccines, Others)
- By Source (Microbes, Humans, Others (Rodents, Plants, etc.))
- By Region (North America, South America, Europe, Asia-Pacific, Middle East, and Africa)
Monoclonal Antibodies to Witness Significant Growth in the Global Biologics Market
Based on the drug-class segment, the market is further bifurcated into Recombinant Proteins, Monoclonal Antibodies, Blood and Blood Components, Cellular and Gene Therapy, Vaccines, and Others. Out of these, Monoclonal Antibodies (mAbs) have emerged as a potent solution for treating a range of ailments, such as cancers, autoimmune disorders, and infections. The advancements in antibody engineering & hybridoma technologies have paved the way for the development of precise & effective mAbs, thereby driving the growth of the Global Biologics Market. Moreover, the increasing prevalence of diseases like rheumatoid arthritis (RA), various cancers, viral infections, and gastrointestinal disorders, among others, has fueled the demand for monoclonal antibodies, as they are widely utilized across several therapeutic areas to combat these conditions.
North America to Overpower the Other Regions
Geographically, North America has maintained a significant share of the Global Biologics market. This dominance has been attributed to the robust healthcare infrastructure & substantial investments in biopharmaceutical research within the region. With North America being home to numerous biopharmaceutical companies and research institutions fostering innovation, it is poised for promising market growth in the future.
Furthermore, the conducive regulatory environment has played a pivotal role in driving market growth by facilitating accelerated approvals for biologics. Also, the increasing prevalence of various diseases, coupled with heightened awareness among affected individuals & their openness to exploring new treatment options, is expected to further drive the demand for biologics in North America in the years to come.
Need additional assistance?
- Looking for more assistance? Connect with our experienced analysts for insights into current market trends.
- Customize your report by adding specific segments and countries to meet your needs. Gain a significant competitive edge by learning how to leverage these insights to enhance your operations and boost revenue.
- For further support, don’t hesitate to reach out to our analysts.
Customize This Report to Fit Your Requirement, We’re offering discounts on Purchase of the Report, Get It Today – https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Browse More Report:
- Latin America Tire Market Analysis
- Global Energy Drinks Market Analysis
- Global Food Waste Disposer Market Analysis
- Global Dietary Supplements Market Analysis
- Global Cell & Gene Therapy Drug Delivery Devices Market Analysis
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India